A carregar...
ERCC1 protein as a guide for individualized therapy of late-stage advanced non-small cell lung cancer
Excision repair cross-complementation group 1 (ERCC1) protein has been associated with cisplatin resistance. The objective of this study was to investigate the correlation between ERCC1 protein levels and the therapeutic effect of individualized therapy in advanced non-small cell lung cancer (NSCLC)...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440707/ https://ncbi.nlm.nih.gov/pubmed/22977580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.276 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|